| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.83B | 2.43B | 2.34B | 2.17B | 1.94B |
| Gross Profit | 907.00M | 2.23B | 536.60M | 1.27B | 1.17B |
| EBITDA | 1.36B | 1.16B | 886.70M | 1.03B | 997.40M |
| Net Income | 371.00M | 229.40M | 140.20M | 132.20M | -87.20M |
Balance Sheet | |||||
| Total Assets | 17.57B | 15.91B | 14.20B | 12.24B | 11.59B |
| Cash, Cash Equivalents and Short-Term Investments | 796.00M | 1.02B | 953.20M | 34.20M | 115.40M |
| Total Debt | 10.98B | 9.70B | 8.27B | 7.30B | 6.73B |
| Total Liabilities | 15.73B | 14.14B | 12.37B | 11.27B | 10.33B |
| Stockholders Equity | 1.84B | 1.77B | 1.83B | 970.60M | 1.26B |
Cash Flow | |||||
| Free Cash Flow | -972.00M | -680.50M | -356.40M | -190.20M | 62.90M |
| Operating Cash Flow | 924.00M | 912.30M | 813.30M | 549.50M | 709.50M |
| Investing Cash Flow | -1.95B | -1.54B | -1.19B | -721.70M | -650.10M |
| Financing Cash Flow | 771.00M | 718.60M | 1.30B | 93.20M | 4.30M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | £29.25B | 16.49 | 7.09% | 2.98% | 1.78% | -50.72% | |
68 Neutral | £10.10B | 6.46 | 27.72% | 4.45% | 21.96% | 121.69% | |
67 Neutral | £2.50B | 9.64 | 3.09% | 6.56% | 19.50% | ― | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
62 Neutral | £63.74B | 19.37 | 8.47% | 4.15% | -3.76% | 8.19% | |
59 Neutral | £9.07B | 2.73 | 1.68% | 2.86% | -2.11% | -104.48% | |
55 Neutral | £9.42B | 25.02 | 20.35% | 4.50% | 16.66% | 61.14% |